NAFDAC Corrects Deleject Needle Alert, Confirms Products on the Market Are Safe

The National Agency for Food and Drug Administration and Control (NAFDAC) has withdrawn a recently published safety alert concerning Deleject Disposable Needles, saying it was posted on its website by mistake. The agency explained that the issue referenced in the alert had already been investigated months earlier, appropriate regulatory actions were taken, and the case had been closed. NAFDAC has now reassured healthcare professionals, distributors, and the public that Deleject Disposable Needles currently available in Nigeria are considered safe and meet the required quality standards.

Me & You Pharma Takeaways

• NAFDAC says its recent Deleject needle alert was published in error.
• The product issue had already been investigated and resolved several months before the mistaken publication.
• Deleject Disposable Needles currently in circulation are considered safe and meet regulatory quality standards.
• NAFDAC says there is no ongoing safety or quality concern affecting the products on the market.
• Healthcare professionals and consumers should disregard the erroneous alert.
• Suspected product defects or adverse events should still be reported through NAFDAC’s official channels.

What Happened?

NAFDAC has clarified that Public Alert No. 042/2026, which referred to whitish particulate matter in Deleject Disposable Needle Batch No. 240605, should not have been published.

According to the agency, the underlying complaint had already gone through its regulatory review process several months earlier. Investigations were completed, corrective measures were implemented, and the matter was considered resolved before the alert was mistakenly uploaded to the agency’s website.

Following this clarification, NAFDAC emphasized that Deleject Disposable Needle products currently being distributed in Nigeria have met the necessary quality requirements and remain suitable for use.

Why It Matters To Your Health

Medical device safety alerts often influence the decisions of hospitals, pharmacies, healthcare workers, and patients. When an alert suggests that a product may have a defect, it can understandably create concern about whether that product is safe to use.

NAFDAC’s latest clarification is therefore important because it changes the understanding of the earlier publication. Rather than indicating a new or ongoing quality problem, the agency says the previously published alert referred to an issue that had already been investigated and resolved.

The agency has stated that Deleject Disposable Needles currently available through legitimate distribution channels comply with regulatory quality expectations. This reassurance helps healthcare providers continue using approved products with confidence while reducing unnecessary concern among patients.

The situation also highlights how regulatory agencies continue monitoring medical products even after investigations are completed. When errors occur in public communication, issuing timely corrections helps ensure that healthcare decisions are based on the most accurate information available.

What You Can Do

If you came across the earlier Deleject needle alert, rely on NAFDAC’s latest clarification rather than treating it as a current safety warning.

Healthcare facilities, pharmacies, and distributors can continue using approved Deleject Disposable Needles supplied through authorized channels.

As with any medical device, inspect products before use and report any visible defects or unexpected problems to NAFDAC through its official reporting platforms.

If you have concerns about a medical device used during your treatment, speak with your pharmacist, doctor, or another qualified healthcare professional instead of relying on unverified information shared online.

Understanding The Issue

Medical device regulation does not end once a product enters the market. Regulatory agencies continue monitoring products through consumer complaints, inspections, laboratory testing, and post-market surveillance to identify any issues that may affect patient safety.

In this case, NAFDAC explained that the Deleject matter referenced in the earlier publication had already completed that regulatory process. The agency stated that the issue had been investigated months earlier, appropriate actions were taken, and the case had been closed before the recent publication was mistakenly posted.

Corrective actions are an important part of quality assurance. When manufacturers identify or are notified of a product issue, they may be required to investigate its cause, implement improvements, and demonstrate that those improvements are effective before regulators consider the matter resolved.

One common misconception is that every regulatory alert means a product currently on the market is unsafe. In reality, some communications relate to historical incidents, completed investigations, or administrative updates. This is why checking the latest official guidance is essential before making healthcare decisions.

NAFDAC’s latest position is that Deleject Disposable Needles currently in distribution are in good and acceptable condition and have satisfied the applicable quality requirements expected for their use. The agency also stated that there is no evidence of an ongoing quality or safety risk affecting healthcare providers, patients, distributors, or the wider public.

The correction also reinforces the importance of obtaining medical products through licensed suppliers and following updates from official regulatory authorities rather than relying on incomplete or outdated information circulating on social media.

When To Speak With A Healthcare Professional

Speak with a healthcare professional if:

• You notice an unusual defect or damage on a medical device before use.
• You experience an unexpected reaction following an injection or medical procedure.
• You have concerns about the quality or authenticity of a medical device.
• You need clarification about a product safety update or recall.

Healthcare professionals and consumers should continue reporting suspected product defects or adverse events to NAFDAC through its official reporting channels.

Join The Me & You Pharma Community

Stay informed with trusted medication updates, medical device safety alerts, pharmacist-led health advice, and practical wellness tips. Join the Me & You Pharma community to receive reliable health information and stay updated on important regulatory developments that affect you and your family.

Medical Disclaimer

This article is provided for general educational and informational purposes only and is based on information released by the National Agency for Food and Drug Administration and Control (NAFDAC).

.